CannIntelligence.com provides independent, in-depth regulatory and market data and intelligence for the global cannabis and cannabinoid sector.
LATEST ALERTS
View all Cannabis and cannabinoid in North America
Market reports
Full-length in-depth reports with detailed data and analysis for individual markets around the world
Regulatory reports
Comprehensive legal reports outlining how the sector is regulated, interpretation of the laws and relevant bodies
Market data
Up-to-date real-time information and insights on brands, pricing and retail across selected markets
Regulatory databases
Regularly updated global regulations currently in place, compiled into easy-to-read maps and tables
Infographics
Highlights of the data and analysis that can be found in our full-length market reports
As of February of 2022, subscribers will be able to view and filter individual regulatory alerts per region. If you want to get our alerts compilations, visit our alerts Round-up section.
Daily news alerts
Our legal experts track the evolving regulation around the cannabinoid and cannabis sector on a daily basis. These alerts are then compiled into our Round-up section.
2nd February 2023
US - Mississippi: House Bill (HB) 1158 was passed by the House and now heads to the Senate. HB 1158 would modify the state's medical cannabis laws in various ways, including expressly excluding hemp from medical cannabis requirements, allowing dispensaries to sell topical cannabis products to adults (21+) without medical cannabis cards, and preventing regulations from prohibiting the "display on dispensary websites of pictures of products that the dispensary sells".1st February 2023
- US - Virginia: Senate Bill (SB) 788 was passed by the Senate and now moves to the House. SB 788 would make several changes to the medical cannabis programme, including shifting the programme's oversight from the Board of Pharmacy to the Cannabis Control Authority.
1st February 2023
- US - Washington DC: Mayor Muriel Bowser has signed Bill 24-0113 into law. The bill aims to increase access to medical cannabis by allowing medical cannabis patients to obtain cannabis from any dispensary in the district, permitting delivery and kerbside pickup, and increasing the number of licensed dispensaries.
1st February 2023
- US - Mississippi: Senate Bill (SB) 2771, which would have removed cannabis from the controlled substances list, and House Bill (HB) 338, which would have allowed the sale of recreational cannabis, have both failed in committee.
1st February 2023
- US - North Dakota: House Bill (HB) 1164 and HB 1202, both which would have allowed medical cannabis in the form of edibles, have been voted down and failed. HB 1202 received a majority vote (55-37) on the House floor but came up short of the two-thirds approval necessary to advance.
1st February 2023
- US - Federal: Republican Representative Greg Steube has introduced a bill (HR610) in the House to reschedule cannabis from Schedule I to Schedule III under the federal Controlled Substances Act. Steube introduced the same bill in the previous two sessions of Congress but did not receive a hearing on it either time under the then Democrat-controlled House. It seems unlikely that the now Republican-led House will pass the bill, though, particularly in light of the ongoing rescheduling review on cannabis requested by president Joe Biden.
31st January 2023
US - California: The California Department of Cannabis Control (DCC) has written to state attorney general Rob Bonta arguing that allowing California to enter into interstate cannabis commerce would not put it at legal risk and requesting an opinion on the subject. Bonta’s opinion, if he provides one, could have significant legal implications due to a California law passed last year. That new law would allow for interstate commerce of cannabis and would be triggered by one of four events, one of which is the AG issuing a written opinion that interstate commerce of cannabis “will not result in significant legal risk to the State of California under the federal Controlled Substances Act”.
27th January 2023
- US - Mississippi: Medical cannabis sales have officially begun in Mississippi, press reports.
27th January 2023
- US - Federal: The US Department of Agriculture (USDA)'s Agricultural Marketing Service (AMS) announced that it will be issuing a free national weekly hemp report for the purpose of "provid[ing] unbiased, timely, and accurate data to help industry stakeholders make business decisions". The first report contains information on advertised pricing for hemp seed and protein and on hemp imports.
27th January 2023
- Mexico: The congress for the state of Baja California approved an initiative to decriminalise cannabis for medical purposes, press reports. The measure is still dependent on the federal government implementing its own medical cannabis programme. Despite the federal Supreme Court ruling that failing to do so violates the constitution and the federal government issuing regulations for medical cannabis, the federal government has stalled in implementing its medical cannabis programme.
27th January 2023
- Canada: Health Canada has asked some federally licensed cannabis companies to halt the sales of certain ingestible cannabis products that are incorrectly classified and labelled as extracts rather than edibles, media reports. With regard to packaging restrictions, the distinction is important because any cannabis product classified as an extract has more allowable THC per package than a product classified as an edible. Health Canada has determined that the products in question are consumed in the same manner as food, and therefore fit the definition of edible cannabis.
